Shahrzad Irani

Shahrzad Irani practices at Pain Clinics of Central California, Inc. in Modesto, California.

Shahrzad Irani's NPI, 1487348876, was assigned on June 7, 2023. Shahrzad Irani holds California license F05230868.

Shahrzad Irani's primary practice is Pain Clinics of Central California, Inc., at 1317 Oakdale Rd, Modesto, CA 95355 in Stanislaus County. The practice phone is (833) 478-1818.

Shahrzad Irani's primary practice is Pain Clinics of Central California, Inc. in Modesto, California. Shahrzad Irani is also affiliated with Community Regional Medical Center. The medical group on file is Pain Clinics of Central California. Dmand AI also links Shahrzad Irani to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Shahrzad Irani practices, 4 sites in all. Vendor and product names are available with a free account.

Family is Shahrzad Irani's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Shahrzad Irani is licensed in California.

Dmand AI lists arthritis, fibromyalgia and chronic pain, joint pain, lower back pain and thoracic spine disorders among the conditions Shahrzad Irani treats.

CMS data shows 880 Medicare services from Shahrzad Irani across 9 procedure codes in 2024, for 172 Medicare patients. Medicare paid $45,131 for them. Every service was in an office.

CMS counts 172 Medicare patients who saw Shahrzad Irani in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have arthritis, and 74% have high blood pressure. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Shahrzad Irani's median patient age at 60, with 64% women.

In 2024, Shahrzad Irani wrote 1,901 Medicare Part D claims for 436 patients. 97% of them were for generic drugs. CMS names the drug for 1,793 of them, across 24 drugs with 11 or more claims each, at $79,867 in total drug cost.

Shahrzad Irani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Shahrzad Irani as offering telehealth.

CMS Open Payments shows 92 general payments to Shahrzad Irani from 11 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 56% of the total. Abbott Laboratories paid the most, $2,057.